Association of the Nordic Cancer Registries ANCR 29th - 30th August 2012 Oslo - Norway Soria Moria by Theodor Kittelsen (1881) Programme & Abstracts
Soria Moria Conference hotel Voksenkollveien 60, 0790Oslo, Norway, Tel: +47 23 22 24 00 www.soriamoria.no
ANCR's Scientific Programme - 29th August 10.00-11.00 Registration 11.00-11.15 Opening Giske Ursin, Cancer Registry of Norway New concepts in epidemiology Chairs: Risto Sankila/Trude Eid Robsahm 11.15-12.00 Answering the "what if": Counterfactual analysis in epidemiology Keynote Speech: Kjetil Røysland, Dept. of Research, Cancer Registry of Norway/Institute of Basic Medical Sciences, University of Oslo 12.00-12.15 Causal inference: Estimation of direct and indirect effects in survival analysis Odd Aalen, Dept. of Biostatistics, University of Oslo/Cancer Registry of Norway 12.15-12.30 Estimating the loss in expectation of life due to cancer using flexible parametric survival Models Therese M-L Andersson, Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute 12.30-12.45 How can we make cancer survival statistics more useful for patients and clinicians - an application using localized prostate cancer in Sweden Sandra Eloranta, Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute 12.45-13.00 Conditional survival statistics in standard cancer registry reporting Bjørn Møller, Dept. of Registration, Cancer Registry of Norway 13.00-14.00 Lunch Cancer Screening Chairs: Nea Malila/Hilde Langseth 14.00-14.15 Is cancer screening worth the effort? Elsebeth Lynge, Dept. of Public Health, University of Copenhagen 14.15-14.30 The age-specific effectiveness of cervical cancer screening? Stefan Lönnberg, Cervical Cancer Screening Programme, Cancer Registry of Norway 14.30-14.45 Effect of screening programs on population wide breast cancer mortality Harald Weedon-Fekjær, Dept. of Biostatistics, University of Oslo 14.45-15.00 Human papillomavirus testing in the Norwegian cervical cancer screening Mari Nygård, Dept. of Research, Cancer Registry of Norway 15.00-15.15 Prevalence to incidence ratio as a quality indicator for colorectal cancer screening Nea Malila, Mass Screening Registry, Finnish Cancer Registry 15.15.-15.30 Implementing Cost-Effective and Agile ICT Solutions with Open Source Software in Finnish Cancer Tuomas Lepola, Cancer Society of Finland 15.30-15.45 Break
Poster Session Moderator: Eero Pukkala 15.45-15.50 Non-academic work at the Mass Screening Registry Minna Heikkilä, Mass Screening Registry, Finnish Cancer Registry 15.50-15.55 Monitoring Finnish breast cancer screening programme over the period 1992-2009 Tytti Sarkeala, Mass Screening Registry, Finnish Cancer Registry 15.55-16.00 Lifestyle and quality of life effects of colorectal cancer screening. Population-based survey study in Finland 2010-2012 Sanni Helander, Mass Screening Registry, Finnish Cancer Registry 16.00-16.05 Food quality index as a tool describing differences in diet quality among colorectal cancer screening attendees, non-attendees and controls Jonna Fredman, Mass Screening Registry, Finnish Cancer Registry 16.05-16.10 Association of symptoms of colon cancer patients with tumor location and TNM tumor stage Laufey Tryggvadottir, The Icelandic Cancer Registry 16.10-16.15 Impact of comorbidity on management and mortality in women diagnosed with breast cancer Anders Berglund, Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute 16.15-16.20 Trends in incidence of Type 1 and Type 2 endometrial cancer in Denmark 1978-2009 among non-hysterectomized women Mette Tuxen Faber, Danish Cancer Society Research Center 16.20-16.25 Persistence and reappearance of carcinogenic human papillomavirus (HPV) after conization Camilla Flarup Glosvig, Danish Cancer Society Research Center 16.25-16.30 Prevalence and type-distribution of human papillomavirus among men in Tanzania Tina Bech Olesen, Danish Cancer Society Research Center 16.30-16.35 Baseline PSA measures to predict future prostate cancer risk and stage at diagnosis in the Danish prospective Diet, Cancer and Health cohort Signe Benzon Larsen, Danish Cancer Society Research Center 17.00-19.15 Social activities - Excursion by bus & guiding - Holmenkollen Ski Jump 19.45-20.15 Music & Aperitif 20.15- Dinner
ANCR's Scientific Programme - 30th August Visions for Nordic cancer registry collaborations in the future 09.00-09.45 Keynote Speech: Hans Henrik Storm, Danish Cancer Society Flagships of Nordic collaboration Chairs: Jørgen Olsen/Mari Nygård 09.45-10.00 Work and cancer: in-dept studies initiated by the NOCCA project Laufey Tryggvadottir, The Icelandic Cancer Registry 10.00-10.15 NORDCAN - status and new facilities Gerda Engholm, NORDCAN secretariat, Danish Cancer Society 10.15-10.30 Break Poster Session Moderator: Elisabete Weiderpass 10.30-10.35 Variation in reporting of key parameters in pathology reports and the benefit of using structured templates Siri Larønningen, Dept. of Registration, Cancer Registry of Norway 10.35-10.40 Cancer registration in the Faroe Islands - updated and complete Niels Christensen, NORDCAN secretariat, Danish Cancer Society 10.40-10.45 Quality of the Finnish Cancer Registry: IARC-CHECKs vs. reality checks Minna Merikivi, Finnish Cancer Registry 10.45-10.50 Usage of Korean Cancer Registry for community-based cohort Young-Joo Won, Risk Appraisal & Prevention Branch, National Cancer Center, Korea 10.50-10.55 Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway Inger Kristin Larsen, Dept. of Registration, Cancer Registry of Norway 10.55-11.00 Ovarian cancer risk in Finnish women using postmenopausal hormone therapy - a case control study Tadeusz Dyba, Institute for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry 11.00-11.05 Angiotensin receptor blockers and risk of cancer. Use of prescription data in linkages with the Cancer Registry of Norway Tom Børge Johannesen, Dept. of Registration, Cancer Registry of Norway 11.05-11.10 Cancer in childhood, adolescence and young adults: A population-based study of changes in risk of early cancer death during four decades in Norway Sara Ghaderi, Dept. of Public Health and Primary Health Care, University of Bergen 11.10-11.15 The harm of smoking among Norwegian women Elisabete Weiderpass, Dept. of Research, Cancer Registry of Norway 11.30-12.30 Lunch
Etiology and prognosis Chairs: Kristina Kjærheim/Tom B. Johannesen 12.30-12.45 Spatial and familial clustering of different tumour types in Finland - Finnish Cancer Registry as key element of the Center of Excellence on Cancer Genetics Miia Artama, Inst. for Statistical and Epidemiological Cancer Research, Finnish Cancer Registry 12.45-13.00 Gene variations in sex hormone pathways and the risk of testicular cancer: A caseparent triad study in a Norwegian-Swedish population Tom Grotmol, Dept. of Research, Cancer Registry of Norway 13.00-13.15 Breast cancer and ductal carcinoma in situ (DCIS) among women with a history of moderate or high grade cervical intraepithelial neoplasia (CIN) or adenocarcinoma in situ (AIS): a register-based study Bo Terning Hansen, Dept. of Research, Cancer Registry of Norway 13.15-13.30 Can stage at diagnosis explain the poorer prognosis reported in women with pregnancyassociated breast cancer? Anna L. V. Johansson, Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute Survival II Chairs: Åsa Klint/Bjørn Møller 13.30-13.45 Social inequality and cancer survival - a study of social position and stage at diagnosis and prognosis after head and neck cancer Maja Halgren Olsen, Danish Cancer Society Research Center 13.45-14.00 Exploratory analysis of the differences in prostate cancer survival between Denmark, Iceland, and Sweden - A high-resolution study Gerda Engholm, Dept. of Cancer Prevention and Documentation, Danish Cancer Society Poster Session Moderator: Laufey Tryggvadottir 14.00-14.05 Socioeconomic position and survival after cervical cancer - the influence of stage at diagnoses, treatment, health status and health behavior Else Ibfelt, Danish Cancer Society Research Center 14.05-14.10 In Sickness and in Health: the Role of Marital Partners in Cancer Survival Astri Syse, Dept. of Research, Cancer Registry of Norway 14.10-14.15 The effect of beta blocker use on the survival of prostate cancer patients: A cohort study of 24.572 Norw. prostate cancer patients Helene Hartvedt Grytli, Dept. of Tumor Biology, Inst. of Cancer Research, Oslo University Hospital, Radium hospital 14.15-14.20 Long-term outcomes according to prostate cancer risk category in a nation-wide, population-based cohort Fredrik Sandin, Regional Cancer Centre, Uppsala 14.20-14.25 Estimating the cure proportion of malignant melanoma, a population-based study in 2 regions in Sweden Therese M-L Andersson, Dept. of Medical Epidemiology and Biostatistics, Karolinska Institute 14.25.-14.30 Birth outcomes among female adult cancer survivors: Parity might matter
Hanne Stensheim, Dept. of Registration, Cancer Registry of Norway 14.30-14.-35 A comprehensive review on risk for second primary cancers (SPCs) among cancer survivors in the Netherlands (1989-2008) Lifang Liu, Dept. of Public Health, Erasmus University Medical Center, Rotterdam 14.45-15.05 Future challenges for cancer registries Timo Hakulinen, Finnish Cancer Registry 15.05-15.25 Final Note Giske Ursin, Cancer Registry of Norway